Polymeric nanoparticles for pulmonary protein and DNA delivery

Acta Biomaterialia

Volumn 10, Issue 6, 2014, Pages 2643-2652

  Menon, Jyothi U ^a,b   Ravikumar, Priya ^b   Pise, Amruta ^a,b   Gyawali, Dipendra ^a,b   Hsia, Connie C W ^b   Nguyen, Kytai T ^a,b  

^a The University of Texas at Arlington   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

DNA; Nanoparticles; Nebulization; Protein; Pulmonary

Indexed keywords

BIOCOMPATIBILITY; BIOLOGICAL ORGANS; CHITOSAN; DEIONIZED WATER; DNA; POLYETHYLENE GLYCOLS; PROTEINS; SALINE WATER; SURFACE TREATMENT;

BIOLOGICAL AGENTS; DNA DELIVERY; IN-VITRO; NEBULISATION; POLY LACTIC-CO-GLYCOLIC ACID; POLY(LACTIC-CO-GLYCOLIC ACID); POLYMERIC NANOPARTICLES; PULMONARY; PULMONARY PROTEIN DELIVERIES; YELLOW FLUORESCENT PROTEINS;

NANOPARTICLES;

ALGINIC ACID; CHITOSAN; GELATIN; MACROGOL; NANOCARRIER; PLASMID DNA; POLYGLACTIN; RECOMBINANT ERYTHROPOIETIN; YELLOW FLUORESCENT PROTEIN; DNA; NANOPARTICLE; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DNA CONTENT; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; DRUG STABILITY; DRUG UPTAKE; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIGHT SCATTERING; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; MOLECULAR STABILITY; NANOENCAPSULATION; NEBULIZATION; NEBULIZER; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; SURFACE CHARGE; ZETA POTENTIAL; ANIMAL; LUNG; METABOLISM; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; DNA; DRUG DELIVERY SYSTEMS; LUNG; NANOPARTICLES; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84899660553     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.01.033     Document Type: Article

References (50)

1. Andrade F, Videira M, Ferreira D, Sarmento B. Nanocarriers for pulmonary administration of peptides and therapeutic proteins. Nanomedicine 2011;6:123-41.
2. Beck-Broichsitter M, Merkel OM, Kissel T. Controlled pulmonary drug and gene delivery using polymeric nano-carriers. J Control Release 2012;161:214-24.
3. Terzano C, Allegra L, Alhaique F, Marianecci C, Carafa M. Non-phospholipid vesicles for pulmonary glucocorticoid delivery. Eur J Pharm Biopharm 2005;59:57-62.
4. Dandekar P, Venkataraman C, Mehra A. Pulmonary targeting of nanoparticle drug matrices. J Aerosol Med Pulm Drug Deliv 2010;23:343-53.
5. Smola M, Vandamme T, Sokolowski A. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. Int J Nanomed 2008;3:1-19.
6. Sung JC, Pulliam BL, Edwards DA. Nanoparticles for drug delivery to the lungs. Trends Biotechnol 2007;25:563-70.
7. Sham JOH, Zhang Y, Finlay WH, Roa WH, Lobenberg R. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung. Int J Pharm 2004;269:457-67.
8. Nesamony J, Singh PR, Nada SE, Shah ZA, Kolling WM. Calcium alginate nanoparticles synthesized through a novel interfacial cross-linking method as a potential protein drug delivery system. J Pharm Sci 2012;101:2177-84.
9. Menon JU, Kona S, Wadajkar AS, Desai F, Vadla A, Nguyen KT. Effects of surfactants on the properties of PLGA nanoparticles. J Biomed Mater Res A 2012;100:1998-2005.
10. Bivas-Benita M, Romeijn S, Junginger HE, Borchard G. PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium. Eur J Pharm Biopharm 2004;58:1-6.
11. Ungaro F, d'Angelo I, Miro A, La Rotonda MI, Quaglia F. Engineered PLGA nanoand micro-carriers for pulmonary delivery: challenges and promises. J Pharm Pharmacol 2012;64:1217-35.
12. Ungaro F, d'Angelo I, Coletta C, d'Emmanuele di Villa Bianca R, Sorrentino R, Perfetto B, et al. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers. J Control Release 2012;157:149.
13. Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Int J Pharm 2009;382:198-204.
14. Grabowski N, Hillaireau H, Vergnaud J, Santiago LA, Kerdine-Romer S, Pallardy M, et al. Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells. Int J Pharm 2013;454:686-94.
15. Hara K, Tsujimoto H, Tsukada Y, Huang CC, Kawashima Y, Tsutsumi M. Histological examination of PLGA nanospheres for intratracheal drug administration. Int J Pharm 2008;356:267-73.
16. El-Sherbiny IM, McGill S, Smyth HDC. Swellable microparticles as carriers for sustained pulmonary drug delivery. J Pharm Sci 2010;99:2343-56.
17. Ely L, Roa W, Finlay WH, Lobenberg R. Effervescent dry powder for respiratory drug delivery. Eur J Pharm Biopharm 2007;65:346-53.
18. Fernandez Tena A, Casan Clara P. Deposition of inhaled particles in the lungs. Arch Bronconeumol 2012;48:240-6.
19. Patlolla RR, Chougule M, Patel AR, Jackson T, Tata PNV, Singh M. Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers. J Control Release 2010;144:233-41.
20. Beck-Broichsitter M, Gauss J, Packhaeuser CB, Lahnstein K, Schmehl T, Seeger W, et al. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model. Int J Pharm 2009;367:169-78.
21. Manca ML, Mourtas S, Dracopoulos V, Fadda AM, Antimisiaris SG. PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization. Colloids Surf B Biointerfaces 2008;62:220-31.
22. Yang M, Yamamoto H, Kurashima H, Takeuchi H, Yokoyama T, Tsujimoto H, et al. Design and evaluation of inhalable chitosan-modified poly (dl-lactic-coglycolic acid) nanocomposite particles. Eur J Pharm Sci 2012;47:235-43.
23. Al-Qadi S, Grenha A, Carrion-Recio D, Seijo B, Remunan-Lopez C. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. J Control Release 2012;157:383-90.
24. Shutava TG, Balkundi SS, Vangala P, Steffan JJ, Bigelow RL, Cardelli JA, et al. Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols. ACS Nano 2009;3:1877-85.
25. Gan Q, Wang T, Cochrane C, McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces 2005;44:65-73.
26. Rajaonarivony M, Vauthier C, Couarraze G, Puisieux F, Couvreur P. Development of a new drug carrier made from alginate. J Pharm Sci 1993;82:912-7.
27. Ahmad Z, Sharma S, Khuller GK. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int J Antimicrob Agents 2005;26:298-303.
28. Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, et al. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 2007;28:869-76.
29. Marques MR, Loebenberg R, Almukainzi M. Simulated biological fluids with possible application in dissolution testing. Dissolution Technol 2011;18:15-28.
30. Mainardes RM, Evangelista RC. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm 2005;290:137-44.
31. Han E-J, Chung A-H, Oh I-J. Analysis of residual solvents in poly(lactide-coglycolide) nanoparticles. J Pharm Invest 2012;42:251-6.
32. Yang S-J, Chang S-M, Tsai K-C, Chen W-S, Lin F-H, Shieh M-J. Effect of chitosanalginate nanoparticles and ultrasound on the efficiency of gene transfection of human cancer cells. J Gene Med 2010;12:168-79.
33. Mansour HM, Rhee YS, Wu X. Nanomedicine in pulmonary delivery. Int J Nanomed 2009;4:299-319.
34. Gan Q, Wang T. Chitosan nanoparticle as protein delivery carrier - systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B Biointerfaces 2007;59:24-34.
35. Chang C-H, Lin Y-H, Yeh C-L, Chen Y-C, Chiou S-F, Hsu Y-M, et al. Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori. Biomacromolecules 2009;11:133-42.
36. Chan JM, Zhang L, Yuet KP, Liao G, Rhee J-W, Langer R, et al. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 2009;30:1627-34.
37. Musumeci T, Ventura CA, Giannone I, Ruozi B, Montenegro L, Pignatello R, et al. PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm 2006;325:172-9.
38. Li Y-P, Pei Y-Y, Zhang X-Y, Gu Z-H, Zhou Z-H, Yuan W-F, et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release 2001;71:203-11.
39. Parveen S, Sahoo SK. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Eur J Pharmacol 2011;670:372-83.
40. Tseng C-L, Wang T-W, Dong G-C, Yueh-Hsiu WuS, Young T-H, Shieh M-J, et al. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting. Biomaterials 2007;28:3996-4005.
41. Grenha A, Grainger CI, Dailey LA, Seijo B, Martin GP, Remuñán-López C, et al. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. Eur J Pharm Sci 2007;31(2):73-84.
42. Gazori T, Haririan I, Fouladdel S, Namazi A, Nomani A, Azizi E. Inhibition of EGFR expression with chitosan/alginate nanoparticles encapsulating antisense oligonucleotides in T47D cell line using RT-PCR and immunocytochemistry. Carbohydr Polym 2010;80:1042-7.
43. Mura S, Hillaireau H, Nicolas J, Le Droumaguet B, Gueutin C, Zanna S, et al. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. Int J Nanomed 2011;6:2591-605.
44. Nam HY, Kwon SM, Chung H, Lee S-Y, Kwon S-H, Jeon H, et al. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release 2009;135:259-67.
45. Chavanpatil MD, Khdair A, Gerard B, Bachmeier C, Miller DW, Shekhar MPV, et al. Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux. Mol Pharm 2007;4:730-8.
46. Chen J, Li S, Shen Q. Folic acid and cell-penetrating peptide conjugated PLGAPEG bifunctional nanoparticles for vincristine sulfate delivery. Eur J Pharm Sci 2012;47:430-43.
47. Lin A, Sabnis A, Kona S, Nattama S, Patel H, Dong J-F, et al. Shear-regulated uptake of nanoparticles by endothelial cells and development of endothelialtargeting nanoparticles. J Biomed Mater Res Part A 2010;93A:833-42.
48. Lesniak A, Salvati A, Santos-Martinez MJ, Radomski MW, Dawson KA, Aberg C. Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc 2013;135:1438-44.
49. He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 2010;31:3657-66.
50. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (d, l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 2002;82:105-14.